A carregar...
Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer
IMPORTANCE: Clinicians frequently use radiotherapy with cetuximab over radiotherapy only or radiotherapy with cisplatin because of a perceived survival and tolerability advantage, but scant data are available to support this perception. OBJECTIVE: To measure the 3 aspects of value (quality, outcomes...
Na minha lista:
| Publicado no: | JAMA Otolaryngol Head Neck Surg |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6802372/ https://ncbi.nlm.nih.gov/pubmed/31621810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoto.2019.2381 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|